Lataa...
Intestinal enteroids/organoids: A novel platform for drug discovery in inflammatory bowel diseases
The introduction of biologics such as anti-tumor necrosis factor (TNF) monoclonal antibodies followed by anti-integrins has dramatically changed the therapeutic paradigm of inflammatory bowel diseases (IBD). Furthermore, a newly developed anti-p40 subunit of interleukin (IL)-12 and IL-23 (ustekinuma...
Tallennettuna:
| Julkaisussa: | World J Gastroenterol |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Baishideng Publishing Group Inc
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6700704/ https://ncbi.nlm.nih.gov/pubmed/31435168 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v25.i30.4125 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|